Evidence map›Paper›PMID 41960511›Full record

ArticleBioinformation2026

A review on levothyroxine therapy and bone age in children with long-standing untreated acquired hypothyroidism.

Abhay Jain, Shailesh Sudani, Zalak Upadhyay

Abstract read
In one paragraph

Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abhay JainDepartment of Pediatrics, American International Institute of Medical Sciences, Udaipur, Rajasthan, India.
Shailesh SudaniDepartment of Pediatrics, Shantabaa Medical College and General Hospital, Amreli, Gujarat, India.
Zalak UpadhyayDepartment of Pediatrics, Shantabaa Medical College and General Hospital, Amreli, Gujarat, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Children with long-standing untreated hypothyroidism often experience delayed bone maturation and impaired linear growth, which can persist even after the initiation of therapy. Therefore, it is of interest to review the effects of levothyroxine therapy on bone age (BA) advancement and growth outcomes in children with hypothyroidism. Known data shows that levothyroxine therapy accelerates bone age progression and improves growth velocity and height outcomes. Early and adequate treatment yields the greatest benefits; however, delayed or prolonged untreated disease limits full height recovery. Thus, timely levothyroxine replacement is essential to minimize growth impairment and preserve adult height potential in pediatric hypothyroidism.

Indexed as

bone agegrowth velocityheight SDSHypothyroidismlevothyroxinepediatricthyroxine

Identifiers

PMID41960511
PMCPMC13058342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.